Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.
Please consider a small donation if you think this website provides you with relevant information
| Date | Title | Source |
|---|---|---|
| 2023-12-18 2:56:48 am | EDSA Stock Earnings: Edesa Biotech Beats EPS for Q4 2023 | InvestorPlace |
| 2023-12-15 1:10:0 pm | Edesa Biotech Reports Fiscal Year 2023 Results | ACCESSWIRE |
| 2023-11-20 1:5:0 pm | Edesa Biotech Reports Final Phase 2b Results for Dermatitis Study | ACCESSWIRE |
| 2023-10-26 1:5:0 pm | Edesa Biotech to Present at Dermatology Drug Development Summit | ACCESSWIRE |
| 2023-10-25 6:10:0 am | Regulators Approve Updated Phase 3 Trial Design for Edesa Biotech’s ARDS Drug | ACCESSWIRE |
| 2023-10-19 6:15:0 am | EDSA: Secures up to CAD$23 Million to Fund Development of EB05… | Zacks Small Cap Research |
| 2023-10-12 9:15:0 am | Edesa Biotech Secures $10 Million Credit Facility with Company Founder | ACCESSWIRE |
| 2023-10-12 9:10:0 am | Edesa Biotech to Receive Up To C$23 Million in Funding from Federal Government | ACCESSWIRE |
| 2023-10-10 6:0:0 am | Edesa Biotech Announces One-for-Seven Reverse Share Split | ACCESSWIRE |
Please consider a small donation if you think this website provides you with relevant information